Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK - Healthcare
₹2,659.80-0.65%
Close on 12 Nov 2026
Price, last 130 trading days
RSI (14)72High: often called overbought
TrendSidewaysPrice vs 20 and 50 day averages
Volume904,1581.0x its 20-day average
MACD86.37MACD above signal (momentum positive)
20-day average₹2,364.82Price is above it
50-day average₹2,379.90Price is above it
200-day average₹2,244.81Price is above it
20-day breakoutNoClosing at a 20-day high
52-week range
Low ₹1,807.00High ₹2,714.00
What this means in plain words
- The price is not clearly above or below both short averages, so the trend looks sideways.
- RSI is 72. Readings above 70 are often called overbought and below 30 oversold, but strong stocks can stay in those zones for a while.
- The price is 2.0% below its 52-week high.
More in Healthcare
Abbott India Ltd.ABBOTINDIA
₹26,600.00+1.88%
Acutaas Chemicals Ltd.ACUTAAS
₹3,996.10+2.02%
Ajanta Pharmaceuticals Ltd.AJANTPHARM
₹3,324.00+0.13%
Anthem Biosciences Ltd.ANTHEM
₹938.45-1.99%
Apollo HospitalsAPOLLOHOSP
₹8,515.00-1.03%
Aster DM Quality Care Ltd.ASTERDM
₹735.90+1.62%
Biocon Ltd.BIOCON
₹370.95+0.79%
Caplin Point Laboratories Ltd.CAPLIPOINT
₹2,386.30-5.32%
Find similar ideas in the Screener All stocks
End-of-day data from a free public feed. It may be delayed or inaccurate. Technical indicators describe past price movement only. This page is for learning and is not investment advice or a recommendation to buy or sell.